SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – CVT, STSA, INDT, ROCC
Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA ), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd.
- Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA ), relating to its proposed sale to Shin Nippon Biomedical Laboratories, Ltd.
- INDUS Realty Trust, Inc. (NASDAQ: INDT ), relating to its proposed sale to affiliates of Centerbridge Partners, L.P. and GIC Real Estate, Inc..
- Under the terms of the agreement, INDT shareholders are expected to receive $67.00 in cash per share they own.
- Under the terms of the agreement, ROCC shareholders are expected to receive 7.49 shares of Baytex and $13.31 in cash per share they own.